Published in Oncotarget on July 21, 2016
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (2004) 24.42
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Cancer. p53, guardian of the genome. Nature (1992) 16.36
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell (1983) 15.09
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell (1979) 14.05
Wild-type p53 activates transcription in vitro. Nature (1992) 11.39
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer (2006) 8.83
Signaling to p53: breaking the MDM2-p53 circuit. Cell (1998) 8.63
Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet (2004) 8.30
The first 30 years of p53: growing ever more complex. Nat Rev Cancer (2009) 8.00
Autoregulation of simian virus 40 gene A by T antigen. Proc Natl Acad Sci U S A (1976) 6.38
Regulation of the specific DNA binding function of p53. Cell (1992) 6.16
Acetylation is indispensable for p53 activation. Cell (2008) 5.70
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell (2006) 5.64
Viral DNA synthesis in cells infected by temperature-sensitive mutants of simian virus 40. J Virol (1974) 5.44
Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature (2005) 5.30
Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell (1984) 5.30
DNA infectivity and the induction of host DNA synthesis with temperature-sensitive mutants of simian virus 40. J Virol (1975) 5.22
THE PURIFICATION OF SIMIAN VIRUS 40. Virology (1964) 4.77
The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol (2003) 4.46
The complexity of p53 stabilization and activation. Cell Death Differ (2006) 3.61
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell (1991) 3.59
Cellular heterogeneity: do differences make a difference? Cell (2010) 3.57
p53 dynamics control cell fate. Science (2012) 3.30
Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog (2010) 3.15
Gangliosides are receptors for murine polyoma virus and SV40. EMBO J (2003) 2.99
Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell (2008) 2.70
Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell (2007) 2.57
Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell (2010) 2.40
Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Natl Acad Sci U S A (2008) 2.37
p53 Research: the past thirty years and the next thirty years. Cold Spring Harb Perspect Biol (2010) 2.34
Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J Virol (2002) 2.33
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev (1992) 2.29
Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol (2011) 2.15
Using or abusing: viruses and the cellular DNA damage response. Trends Microbiol (2007) 2.12
Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A (1998) 2.11
Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol (2011) 2.02
Transcription of simian virus 40. V. Regulattion of simian virus 40 gene expression. J Virol (1975) 1.90
Enhanced transformation of human fibroblasts by origin-defective simian virus 40. Nature (1982) 1.84
Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol (2001) 1.77
SnapShot: p53 posttranslational modifications. Cell (2008) 1.75
Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med (2008) 1.72
Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst) (2004) 1.72
Chromatin immunoprecipitation (ChIP). Cold Spring Harb Protoc (2009) 1.69
Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry (1997) 1.66
N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J Virol (2007) 1.59
Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene (1999) 1.56
Initiation points for DNA replication in nontransformed and simian virus 40-transformed Chinese hamster lung cells. Cell (1977) 1.52
A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ (2013) 1.50
Role of endosomes in simian virus 40 entry and infection. J Virol (2011) 1.46
The semiautonomous replicon: a molecular model for the oncogenicity of SV40. Cold Spring Harb Symp Quant Biol (1975) 1.42
Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1990) 1.39
Sp1 and the 'hallmarks of cancer'. FEBS J (2015) 1.38
Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J Virol (2008) 1.35
Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells. J Virol (2008) 1.32
Ataxia-telangiectasia-mutated (ATM) is a T-antigen kinase that controls SV40 viral replication in vivo. J Biol Chem (2005) 1.32
SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER. Mol Cell (2006) 1.31
P53 promoter selection: choosing between life and death. Cell Cycle (2007) 1.25
We are all individuals: causes and consequences of non-genetic heterogeneity in mammalian cells. Curr Opin Genet Dev (2011) 1.18
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus. Hepatology (2008) 1.17
BK and JC virus: a review. J Infect (2013) 1.11
The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology. PLoS Pathog (2013) 1.10
Pathogens use structural mimicry of native host ligands as a mechanism for host receptor engagement. Cell Host Microbe (2013) 1.09
Wild-type mouse p53 down-regulates transcription from different virus enhancer/promoters. Oncogene (1993) 1.06
Pifithrin-alpha protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ (2009) 1.02
Sp1 transcription factor: A long-standing target in cancer chemotherapy. Pharmacol Ther (2015) 1.00
p53 represses Sp1 DNA binding and HIV-LTR directed transcription. Cell Mol Biol (Noisy-le-grand) (1997) 0.99
Virus strategies for passing the nuclear envelope barrier. Nucleus (2012) 0.98
Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers. Proteome Sci (2008) 0.98
Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A (1993) 0.97
Induction of interferon-stimulated genes by Simian virus 40 T antigens. Virology (2010) 0.97
Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J Virol (1994) 0.95
Immune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk Factors. Front Immunol (2015) 0.95
An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines. Mol Cancer Ther (2005) 0.93
Influenza A virus induces p53 accumulation in a biphasic pattern. Biochem Biophys Res Commun (2009) 0.93
The abundant nuclear enzyme PARP participates in the life cycle of simian virus 40 and is stimulated by minor capsid protein VP3. J Virol (2003) 0.93
Genome guardian p53 and viral infections. Rev Med Virol (2012) 0.92
The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release. PLoS Pathog (2011) 0.92
Dual Role of p53 in Innate Antiviral Immunity. Viruses (2010) 0.91
The p53 tumor suppressor gene and gene product. Princess Takamatsu Symp (1989) 0.91
Rapid method for SV40 titration. J Virol Methods (2009) 0.91
BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions. Curr Opin Organ Transplant (2014) 0.88
Simian virus 40 infection triggers a balanced network that includes apoptotic, survival, and stress pathways. J Virol (2010) 0.87
Simian virus 40 induces lamin A/C fluctuations and nuclear envelope deformation during cell entry. Nucleus (2011) 0.85
p53 represses SV40 transcription by preventing formation of transcription complexes. Oncogene (1995) 0.85
Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Cytotherapy (2014) 0.82
Epitopes on the major capsid protein of simian virus 40. J Biol Chem (1989) 0.81
Polyomavirus T antigens activate an antiviral state. Virology (2015) 0.80
Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives. Semin Oncol (2014) 0.80
Identification of a DNA structural motif that includes the binding sites for Sp1, p53 and GA-binding protein. Nucleic Acids Res (1993) 0.80
Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity. Oncotarget (2016) 0.79
The evidence for human tumor suppressor genes. Princess Takamatsu Symp (1989) 0.76
Expression of p53 after sv40 virus-infection of quiescent cells. Int J Oncol (1994) 0.76
p53 pulses lead to distinct patterns of gene expression albeit similar DNA-binding dynamics. Nat Struct Mol Biol (2017) 0.75